According to Bliss GVS Pharma latest financial reports the total liabilities of BLISSGVS is $28.53M, an decrease of -8.71% to 2022. At the end of 2022 company had $31.25M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Bliss GVS Pharma is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $28.53M | -8.71% |
2022 | $31.25M | 5.39% |
2021 | $29.65M | -10.10% |
2020 | $32.99M | 52.23% |
2019 | $21.67M | - |